An open treatment trial of duloxetine in elderly patients with dysthymic disorder

An open treatment trial of duloxetine in elderly patients with dysthymic disorder

Objective: We evaluated the efficacy and side effects of the selective serotonin and norepinephrine reuptake inhibitor antidepressant duloxetine in older adults with dysthymic disorder. Methods: Patients ≥ 60 years old with dysthymic disorder received flexible dose duloxetine 20–120 mg daily in an o...

Full description

Bibliographic Details
Main Authors:	Nancy Kerner, Kristina D’Antonio, Gregory H Pelton, Elianny Salcedo, Jennifer Ferrar, Steven P Roose, DP Devanand
Format:	Article
Language:	English
Published:	SAGE Publishing 2014-05-01
Series:	SAGE Open Medicine
Online Access:	https://doi.org/10.1177/2050312114533536

Similar Items

Use of aripiprazole in dysthymic disorders. Purposely a case
by: N. Ogando Portilla, et al.
Published: (2023-03-01)

Effectiveness of Spiritually Augmented Psychotherapy on Dysfunctional Attitudes in Patients with Dysthymic Disorder
by: Amrollah Ebrahimi, et al.
Published: (2015-03-01)

L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine
by: Giuseppe Bersania, et al.
Published: (2015-02-01)

Assessment of Mental Disability using Indian Disability Evaluation Assessment Scale in Obsessive Compulsive Disorder and Dysthymic Disorder
by: Roopesh NV Gopal, et al.
Published: (2018-10-01)

Assessment of Quality of Life (QOL) in Obsessive Compulsive Disorder (OCD) and Dysthymic Disorder (DD): A Comparative Study
by: Roopesh Gopal Nariyandada Vasud, et al.
Published: (2015-05-01)

Protective Role of L-3-n-Butylphthalide in Cognitive Function and Dysthymic Disorders in Mouse With Chronic Epilepsy
by: Xiaowen Ye, et al.
Published: (2018-07-01)

Duloxetine in the treatment of generalized anxiety disorder
by: Alan Wright, et al.
Published: (2009-08-01)

The role of duloxetine in the treatment of anxiety disorders
by: Domenico De Berardis, et al.
Published: (2008-07-01)

Duloxetine hydrochloride
by: Mohan Bhadbhade, et al.
Published: (2009-09-01)

The response time to emotional stimuli (including facial expressions photos) during the fMRI scanning in affective disorders: mild and moderate depression and dysthymic disorder
by: M. Ye. Mel’nikov, et al.
Published: (2018-03-01)

Duloxetine for the treatment of generalized anxiety disorder: a review
by: Ahsan Y Khan, et al.
Published: (2008-12-01)

Treatment of major depressive disorder (MDD) or dysthymic disorder (DD) in spinal cord injury (SCI) patients: a protocol for a systematic review and network meta-analysis
by: Hyun-Jin Kim, et al.
Published: (2022-12-01)

Controlled randomized clinical trial of spirituality integrated psychotherapy, cognitive-behavioral therapy and medication intervention on depressive symptoms and dysfunctional attitudes in patients with dysthymic disorder
by: Amrollah Ebrahimi, et al.
Published: (2013-01-01)

Continuation treatment of major depressive disorder: is there a case for duloxetine?
by: Trevor&nbsp;R Norman, et al.
Published: (2010-02-01)

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
by: Watkin John G, et al.
Published: (2004-12-01)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
by: Maria Rosaria Anna Muscatello, et al.
Published: (2019-10-01)

Structure of racemic duloxetine hydrochloride
by: Mohan M. Bhadbhade, et al.
Published: (2023-05-01)

Duloxetine for the management of fibromyalgia syndrome
by: Beth A Scholz, et al.
Published: (2009-07-01)

Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
by: Robinson Rebecca L, et al.
Published: (2011-01-01)

Comparison of duloxetine and methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01)

Effect of the dual action antidepressant duloxetine in the treatment of functional disorders of the gastrointestinal tract
by: G. M. Dyukova, et al.
Published: (2014-12-01)

Efficacy of duloxetine in achieving response and remission
by: Bauer Michael
Published: (2006-02-01)

Duloxetine in the management of chronic musculoskeletal pain
by: Smith EJ, et al.
Published: (2012-06-01)

Efficacy of Hash value in infrared thermogram in assessment of duloxetine for persistent somatoform pain disorder
by: ZENG Shuang, et al.
Published: (2023-10-01)

Effectiveness of Duloxetine for Postsurgical Chronic Neuropathic Disorders after Spine and Spinal Cord Surgery
by: Osahiio Tsuji, et al.
Published: (2021-10-01)

Duloxetine-induced rapid eye movement sleep behavior disorder: a case report
by: Lu Tan, et al.
Published: (2017-11-01)

Acute generalized exanthematous pustulosis induced by duloxetine
by: Numa Deydier, et al.
Published: (2023-06-01)

Predictors of duloxetine adherence and persistence in patients with fibromyalgia
by: Cui Z, et al.
Published: (2012-06-01)

Duloxetine in the management of diabetic peripheral neuropathic pain
by: Boomershine CS, et al.
Published: (2011-07-01)

Opsoclonus-myoclonus syndrome secondary to duloxetine toxicity
by: J. Trigo López, et al.
Published: (2021-04-01)

Duloxetine-induced hyponatraemia in a patient with hypocortisolaemia
by: Mayuko Ikeguchi, et al.
Published: (2020-01-01)

Update on duloxetine for the management of stress urinary incontinence
by: Maya Basu, et al.
Published: (2008-11-01)

The Effectiveness of Acupuncture on Cortisol Levels in a Prostate-Carcinoma Patient under Androgen Deprivation Therapy with Dysthymic Syndrome: A Single-case Experimental Design
by: Bijan Pirnia, et al.
Published: (2020-04-01)

Visual hallucination induced by duloxetine use: a male case diagnosed with generalized anxiety disorder
by: Kemal Utku Yazici, et al.
Published: (2018-07-01)

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
by: Wohlreich Madelaine M, et al.
Published: (2005-01-01)

Clinical effect of flunarizine combined with duloxetine in the treatment of chronic migraine comorbidity of depression and anxiety disorder
by: Junliang Zhu, et al.
Published: (2022-08-01)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
by: Maneeton B, et al.
Published: (2018-08-01)

Simple and Practical Method for the Quantitative High-Sensitivity Analysis of N‑Nitroso Duloxetine in Duloxetine Drug Products Utilizing LC-MS/MS
by: Shohei Fukuda, et al.
Published: (2024-03-01)

Duloxetine versus other anti-depressive agents for depression.
by: Cipriani, A, et al.
Published: (2012)

Use of dual action inhibitor (duloxetine) in diabetic neuropathy
by: Irina Vladimirovna Gur'eva
Published: (2009-03-01)